Skip to main navigation Skip to search Skip to main content

Investigators from Yonsei University Target Non-Small Cell Lung Cancer (Phase I Trial of Cjrb-101 Plus Pembrolizumab In Patients With Metastatic Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Melanoma)

Press/Media: Press / Media

PeriodJun 10 2026

Media coverage

1

Media coverage

  • TitleInvestigators from Yonsei University Target Non-Small Cell Lung Cancer (Phase I Trial of Cjrb-101 Plus Pembrolizumab In Patients With Metastatic Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Melanoma)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date6/10/26
    PersonsMin-Hyun Kim